4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-106531
Chief Financial Officer sold 20,000 shares at $4.51 ($90,200)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gabay Avraham Chief Financial Officer | 2026-10-01 | Sale 10b5-1 | −20,000 | $4.51 | $90,200 | 861,076 | D |
| Open-market sales · 20,000 sh · avg $4.51 · $90,200 | |||||||
Loading xslF345X06/ownership.xml…